Howard Hughes Medical Institute lowered its stake in Syngenta AG (NYSE:SYT) by 9.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,183 shares of the basic materials company’s stock after selling 620 shares during the period. Howard Hughes Medical Institute’s holdings in Syngenta AG were worth $573,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Fiduciary Trust Co. acquired a new position in shares of Syngenta AG in the second quarter valued at approximately $120,000. JPMorgan Chase & Co. increased its holdings in shares of Syngenta AG by 10.7% in the first quarter. JPMorgan Chase & Co. now owns 1,618 shares of the basic materials company’s stock valued at $144,000 after purchasing an additional 157 shares during the period. Sei Investments Co. increased its holdings in shares of Syngenta AG by 0.3% in the second quarter. Sei Investments Co. now owns 1,963 shares of the basic materials company’s stock valued at $182,000 after purchasing an additional 6 shares during the period. Cambiar Investors LLC acquired a new position in shares of Syngenta AG in the second quarter valued at approximately $201,000. Finally, Chevy Chase Trust Holdings Inc. increased its holdings in shares of Syngenta AG by 1.6% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 3,209 shares of the basic materials company’s stock valued at $298,000 after purchasing an additional 50 shares during the period. 0.61% of the stock is currently owned by institutional investors and hedge funds.

A number of brokerages recently weighed in on SYT. BidaskClub raised Syngenta AG from a “strong sell” rating to a “sell” rating in a report on Friday, August 11th. Zacks Investment Research lowered Syngenta AG from a “buy” rating to a “hold” rating in a report on Wednesday, July 5th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $97.50.

COPYRIGHT VIOLATION WARNING: This article was first reported by Daily Political and is the property of of Daily Political. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/09/17/howard-hughes-medical-institute-sells-620-shares-of-syngenta-ag-syt.html.

Shares of Syngenta AG (SYT) traded down 0.74% on Friday, reaching $91.43. The company had a trading volume of 167,548 shares. The company has a market capitalization of $42.21 billion, a price-to-earnings ratio of 40.51 and a beta of 0.98. The stock has a 50 day moving average price of $92.04 and a 200-day moving average price of $91.30. Syngenta AG has a 12 month low of $74.52 and a 12 month high of $93.61.

Syngenta AG Profile

Syngenta AG (Syngenta) is an agribusiness company. The Company operates in the crop protection and seeds business, which is involved in the discovery, development, manufacture and marketing of a range of products designed to improve crop yields and food quality, and in the lawn and garden business, which provides professional growers and consumers with flowers, turf and landscape, and professional pest management products.

Want to see what other hedge funds are holding SYT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Syngenta AG (NYSE:SYT).

Institutional Ownership by Quarter for Syngenta AG (NYSE:SYT)

Receive News & Ratings for Syngenta AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syngenta AG and related companies with MarketBeat.com's FREE daily email newsletter.